UCB's Global Corporate Website

World Psoriasis Day: UCB joins patient advocates in call for awareness and access to care

Image of "Andrea Christopher, Global Communications & Company Reputation"
Posted by
Andrea Christopher, Global Communications & Company Reputation
Today, 29 October, is World Psoriasis Day – an annual opportunity to put the spotlight on psoriasis and psoriatic arthritis. UCB is adding its voice to calls by the psoriasis patient community to treat the disease seriously.

Psoriasis is a common, immune-mediated, inflammatory disease affecting approximately 125 million people around the world, or 3% of the global population. Symptoms include red patches of skin, covered in silvery scales; cracked skin that may bleed and thicken; and severe itching.

The awareness day is organised by the International Federation of Psoriasis Associations (IFPA), which UCB joined recently. The Federation and its 56 countries are organising awareness and advocacy events around the world. The goal is to improve access to treatment, increase understanding and build unity within the psoriasis community.

UCB is also playing its part in improving treatment options for people with psoriasis, with our medicine for adults with moderate to severe psoriasis having been approved in the US and EU earlier this year. We are pleased to bring this therapy to patients in an area of significant unmet need.

We continue to work on bringing new medicines to patients in the field of immunology and lending our support for global patient and advocacy initiatives.

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.


Enter the characters shown in the image.